NCT04324658View on ClinicalTrials.gov

Effect and Tolerance of a Probiotic-based Medical Device Administered to Patients With Irritable Bowel Syndrome

CompletedOBSERVATIONAL

Enrollment

119

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions

Irritable Bowel Syndrome

Interventions

DEVICE

Lactiplus

capsules containing L. gasseri LA806

Trial Locations (1)

Unknown

General practitioners or gastroenterologists consulting in french private offices, Paris

All Listed Sponsors

lead

PiLeJe

INDUSTRY

NCT04324658 - Effect and Tolerance of a Probiotic-based Medical Device Administered to Patients With Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter